Clinical Trial Update: R(+)PPX High Dose Treatment of ALS [Phase 1, Phase 2]

View source ↗

Summary

A ClinicalTrials.gov entry reports completion of a Phase 1/2 study evaluating high-dose R(+)PPX for amyotrophic lateral sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• R(+)PPX (R(+)-PPX)

Snippet

Sponsor: Bennett, James P., Jr., M.D., Ph.D. | Conditions: Amyotrophic Lateral Sclerosis | Phase 1, Phase 2 | Status: COMPLETED